The biopharmaceutical industry contributes to the development of Latin America and the Caribbean both through our societal impact, developing products that help people lead healthier and more productive lives, and through our economic footprint in the countries where we operate.
The innovative medicines produced by the biopharmaceutical industry enable a healthier population and a more resilient health system, contributing to the overall development of the region.